Chapter title |
Hepatitis C virus-specific directly acting antiviral drugs.
|
---|---|
Chapter number | 12 |
Book title |
Hepatitis C Virus: From Molecular Virology to Antiviral Therapy
|
Published in |
Current topics in microbiology and immunology, March 2013
|
DOI | 10.1007/978-3-642-27340-7_12 |
Pubmed ID | |
Book ISBNs |
978-3-64-227339-1, 978-3-64-227340-7
|
Authors |
Delang L, Neyts J, Vliegen I, Abrignani S, Neddermann P, De Francesco R, Leen Delang, Johan Neyts, Inge Vliegen, Sergio Abrignani, Petra Neddermann, Raffaele De Francesco |
Abstract |
The major targets for direct-acting antivirals (DAAs) are the NS3/4A protease, the NS5A protein, and the NS5B polymerase. The latter enzyme offers several target sites: the catalytic domain for nucleoside/nucleotide analogs and different allosteric sites for non-nucleoside inhibitors. Two protease inhibitors have already been approved and more than 40 new NS3/4A, NS5A, or NS5B inhibitors are in development pipeline. Not only these agents can achieve very high cure rates when combined with PEG-IFN and RBV, but have also started to provide promising results when combined in IFN-free, all-oral combinations. In addition to the more canonical drug targets, new alternative viral targets for small molecule drug development are emerging, such as p7 or NS4B. Current research is focusing on defining the most efficacious DAA combination regimens, i.e., those which provide the highest rates of viral eradication, broadest spectrum of action, minimal or no clinical resistance, shortest treatment duration, and good tolerability. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | 50% |
Netherlands | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 3% |
France | 1 | 3% |
Saudi Arabia | 1 | 3% |
Unknown | 32 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 20% |
Researcher | 7 | 20% |
Student > Postgraduate | 5 | 14% |
Student > Master | 3 | 9% |
Other | 2 | 6% |
Other | 7 | 20% |
Unknown | 4 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 26% |
Agricultural and Biological Sciences | 7 | 20% |
Immunology and Microbiology | 4 | 11% |
Biochemistry, Genetics and Molecular Biology | 3 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
Other | 3 | 9% |
Unknown | 6 | 17% |